ArticlePharmacological reports : PR2026

Ketamine for comorbid treatment-resistant depression and substance use disorders: balancing risks and opportunities.

Benjamin D Brody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.